Workflow
医汇集团(08161) - 2024 Q1 - 季度财报
MEDINET GROUPMEDINET GROUP(HK:08161)2023-08-11 11:40

Financial Performance - The group's revenue for the three months ended June 30, 2023, was approximately HKD 29.1 million, an increase of about HKD 0.7 million compared to HKD 28.4 million for the same period in 2022[5]. - The net loss attributable to the company's owners for the period was approximately HKD 960,000, compared to a net profit of approximately HKD 105,000 for the same period in 2022[5]. - The total comprehensive loss for the period was HKD 407,000, compared to a total comprehensive income of HKD 329,000 for the same period in 2022[9]. - The basic loss per share for the period was HKD (2.30), compared to earnings per share of HKD 0.25 for the same period last year[9]. - Revenue for the three months ended June 30, 2023, increased by approximately 2.6% to HKD 29.1 million from HKD 28.4 million for the same period in 2022[26]. - The increase in net loss was primarily due to the absence of a HKD 688,000 subsidy from the Hong Kong government under the "Employment Support" scheme in 2022[24]. Revenue Sources - Revenue from medical services provided to contract clients rose by 57.8% to HKD 10.2 million, up from HKD 6.5 million in the previous year[26]. - Revenue from self-paying patients for medical services increased by 36.5% to HKD 5.5 million, compared to HKD 4.1 million in the prior year[27]. - Revenue from contract clients for dental solutions increased by approximately HKD 120,000, primarily due to an increase in the number of contract clients and individual patients[29]. - Revenue from self-paying patients for dental services decreased from approximately HKD 16.5 million to about HKD 11.9 million, a decline of approximately 27.9%, mainly due to a reduction in patient visits[29]. Expenses - Medical and dental professional service expenses increased to HKD 13.2 million from HKD 11.6 million year-on-year[9]. - The company's other income decreased to HKD 178,000 from HKD 861,000 in the previous year[9]. - Employee costs decreased to HKD 8.6 million from HKD 9.1 million compared to the same period last year[9]. - Other expenses increased by approximately 71.4% from about HKD 2.1 million to approximately HKD 3.6 million, mainly due to increased marketing expenses and the reopening of clinics after lease expirations[38]. - Medical and dental supplies costs decreased by approximately 8.7% from about HKD 2.3 million to approximately HKD 2.1 million, mainly due to a reduction in the quantity of other medical and dental consumables[35]. - Medical and dental professional service expenses rose from approximately HKD 11.6 million in 2022 to about HKD 13.2 million in the current period[24]. - Employee costs decreased by approximately 5.5% from about HKD 9.1 million to approximately HKD 8.6 million, primarily due to a reduction in the number of employees in Hong Kong and mainland China[33]. Dividends and Shareholder Information - The board of directors did not recommend the payment of an interim dividend for the three months ended June 30, 2023[6]. - The company did not propose any interim dividend for the three months ended June 30, 2023[56]. - As of June 30, 2023, Medinet International Limited holds 23,400,000 shares, representing 56.25% of the company's issued share capital[47]. - NSD Capital Limited, Convoy Asset Management Limited, Favour Sino Holdings Limited, Convoy (BVI) Limited, and 康宏環球控股有限公司 each hold 7,800,000 shares, accounting for 18.75% of the company's issued share capital[47]. Corporate Governance - The board confirmed compliance with the GEM Listing Rules regarding securities trading standards for all directors during the three months ended June 30, 2023[55]. - The audit committee reviewed the unaudited condensed consolidated financial statements for the three months ended June 30, 2023[57]. - The company did not purchase, sell, or redeem any of its listed securities during the three months ended June 30, 2023[52]. - There were no known business or interest conflicts involving directors or major shareholders as of June 30, 2023[51]. - The company has adopted a code of conduct for directors' securities transactions, ensuring adherence to trading standards[55]. - The chairman and CEO roles are currently held by the same individual, which the board believes enhances strategic efficiency[53]. - The company has established an audit committee to oversee financial reporting and risk management processes[57].